Represents a Clinical Laboratory in Federal Litigation Against a Global Manufacturer

Buttaci Leardi & Werner represents a clinical laboratory in federal litigation arising from the failure of a COVID-19 testing platform marketed as a turnkey diagnostic solution during the early stages of the pandemic. The laboratory alleged that the system failed to perform as represented, producing inconsistent results that required suspension of testing operations.

The laboratory brought suit against the global manufacturer and related entities in the U.S. District Court for the District of New Jersey. The litigation has involved challenges to defendant identification, contractual privity, and warranty disclaimers in the context of a complex corporate structure.

The court denied multiple motions to dismiss, including arguments that the laboratory had sued improper entities, and permitted claims based on implied contractual obligations to proceed to discovery. The matter involves technical issues related to diagnostic testing systems and laboratory operations, with discovery concluding in October 2025.